Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: OPCH (3-star) is a STRONG-BUY. BUY since 22 days. Simulated Profits (8.12%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $36.45
1 Year Target Price $36.45
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 6.9% | Avg. Invested days 47 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 12/24/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.25B USD | Price to earnings Ratio 25.67 | 1Y Target Price 36.45 |
Price to earnings Ratio 25.67 | 1Y Target Price 36.45 | ||
Volume (30-day avg) 10 | Beta 0.8 | 52 Weeks Range 22.46 - 35.53 | Updated Date 12/25/2025 |
52 Weeks Range 22.46 - 35.53 | Updated Date 12/25/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.78% | Operating Margin (TTM) 5.89% |
Management Effectiveness
Return on Assets (TTM) 6.03% | Return on Equity (TTM) 15.03% |
Valuation
Trailing PE 25.67 | Forward PE 18.94 | Enterprise Value 6101386039 | Price to Sales(TTM) 0.95 |
Enterprise Value 6101386039 | Price to Sales(TTM) 0.95 | ||
Enterprise Value to Revenue 1.1 | Enterprise Value to EBITDA 15.14 | Shares Outstanding 158732706 | Shares Floating 149254776 |
Shares Outstanding 158732706 | Shares Floating 149254776 | ||
Percent Insiders 0.81 | Percent Institutions 107.43 |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health Inc. was formed in 2020 through the merger of Option Care and LHC Group. Option Care, a pioneer in home infusion services, was founded in 1985. LHC Group, a leading provider of post-acute healthcare services, was founded in 1994. This merger created a comprehensive national provider of home-based and community-based healthcare services.
Core Business Areas
- Home Infusion Services: Provides complex intravenous (IV) therapies and other specialized treatments administered in a patient's home. This includes IV antibiotics, hydration, pain management, and biopharmaceuticals.
- Home Health Services: Offers a range of home health services, including skilled nursing, physical therapy, occupational therapy, and speech therapy, to help patients recover and manage chronic conditions at home.
- Hospice Services: Delivers compassionate end-of-life care to patients and their families, focusing on comfort, dignity, and quality of life.
- Palliative Care Services: Provides specialized medical care for people with serious illnesses, focusing on relief from the symptoms and stress of the illness.
Leadership and Structure
Option Care Health Inc. is led by a seasoned executive team with extensive experience in healthcare services. The company operates through a decentralized model with regional and local branches to ensure personalized patient care. Key leadership roles include CEO, CFO, and various operational and clinical VPs.
Top Products and Market Share
Key Offerings
- Home Infusion Therapy: Offers a wide range of infusion therapies for chronic and acute conditions such as infections, autoimmune diseases, and gastrointestinal disorders. Competitors include Coram CVS Specialty Pharmacy, Diplomat Pharmacy (now part of Optum Rx), and BioMatrix Specialty Pharmacy. Market share data for specific services is not publicly disclosed but is estimated to be significant within the specialty infusion market.
- Home Health Care Services: Provides a comprehensive suite of home health services for post-acute care, rehabilitation, and chronic disease management. Competitors include Aveanna Healthcare, Kindred at Home, and Enhabit Home Health & Hospice. Market share is fragmented, with Option Care Health holding a substantial portion due to its extensive network.
- Hospice and Palliative Care: Delivers end-of-life and supportive care services. Competitors include Gentiva Hospice, VITAS Healthcare, and AccentCare Hospice. This segment is also characterized by numerous regional and local providers.
Market Dynamics
Industry Overview
The home-based and community-based healthcare services industry is experiencing significant growth, driven by an aging population, increasing prevalence of chronic diseases, a preference for care at home, and a shift towards value-based care models. Regulatory policies and reimbursement rates from Medicare, Medicaid, and private payers play a crucial role in industry dynamics.
Positioning
Option Care Health Inc. is a leading national provider with a broad geographic reach and a comprehensive service offering. Its competitive advantages include its integrated model, strong relationships with physicians and hospitals, and a focus on patient outcomes and quality of care. The company's scale allows for operational efficiencies and robust clinical expertise.
Total Addressable Market (TAM)
The TAM for home health and hospice services in the US is substantial and growing, estimated to be in the hundreds of billions of dollars. Option Care Health Inc. is well-positioned to capture a significant portion of this market due to its national presence, diversified service lines, and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Extensive national footprint and service network
- Diversified service offerings (infusion, home health, hospice)
- Strong clinical expertise and patient care focus
- Established relationships with referral sources (hospitals, physicians)
- Economies of scale and operational efficiencies
Weaknesses
- Integration challenges post-merger
- Reliance on reimbursement rates from government payers
- Potential for intense competition from local and national players
- Managing a large, dispersed workforce
Opportunities
- Growing demand for home-based care due to demographics and patient preference
- Expansion into new service lines or geographic areas
- Leveraging technology for remote patient monitoring and telehealth
- Partnerships with accountable care organizations (ACOs) and health systems
- Increased focus on chronic disease management at home
Threats
- Changes in government reimbursement policies (e.g., Medicare, Medicaid)
- Increased regulatory scrutiny and compliance burdens
- Intensifying competition and pricing pressures
- Labor shortages and rising labor costs
- Economic downturns affecting healthcare spending
Competitors and Market Share
Key Competitors
- Coram CVS Specialty Pharmacy (CVS Health Corp - CVS)
- Aveanna Healthcare Holdings Inc. (AVAH)
- Enhabit Home Health & Hospice (EHAB)
- VITAS Healthcare (a subsidiary of Chemed Corporation - CHE)
- Kindred at Home (part of Humana - HUM)
Competitive Landscape
Option Care Health Inc. competes in a fragmented but consolidating market. Its advantages lie in its comprehensive service offering and national scale, allowing it to serve a wider patient population and secure favorable contracts. However, it faces intense competition from specialized providers and larger integrated healthcare systems. Its ability to maintain strong clinical outcomes and manage costs effectively is crucial for sustained success.
Major Acquisitions
LHC Group
- Year: 2023
- Acquisition Price (USD millions): 5600
- Strategic Rationale: The merger with LHC Group created a leading national provider of home-based healthcare services, significantly expanding Option Care Health's footprint and service capabilities in home health and hospice.
Growth Trajectory and Initiatives
Historical Growth: Option Care Health Inc. has experienced significant growth through a combination of organic expansion and strategic acquisitions, particularly following the merger of Option Care and LHC Group. The company has consistently expanded its service lines and geographic reach.
Future Projections: Analyst projections generally indicate continued revenue growth for Option Care Health Inc., driven by the favorable industry trends in home-based care. Profitability is also expected to improve due to ongoing operational efficiencies and expansion opportunities.
Recent Initiatives: Continued integration of acquired entities to realize synergies,Investments in technology to enhance patient care and operational efficiency,Expansion of service offerings in high-demand areas,Focus on value-based care models and partnerships
Summary
Option Care Health Inc. is a robust player in the growing home-based healthcare market, benefiting from a strong integrated model and extensive national reach. The company's diversified service lines and strategic acquisitions, such as LHC Group, position it for continued expansion. While facing competitive pressures and regulatory risks, its focus on patient outcomes and operational efficiency bodes well for future performance.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Investor Relations Filings (SEC)
- Industry Research Reports
- Financial News and Analysis Platforms
Disclaimers:
This information is for informational purposes only and does not constitute financial advice. Market share data and financial metrics are estimates and subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://www.optioncarehealth.com |
Full time employees 8000 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.